Financial Gravity Asset Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$193K Buy
14
+4
+40% +$983 0.09% 191
2021
Q2
$283K Buy
+10
New +$2.71K 0.1% 133
2020
Q4
$2K Buy
+10
New +$1.77K ﹤0.01% 328
2019
Q4
$110K Sell
34
-77
-69% -$7.45K 0.08% 282
2019
Q3
$12K Sell
111
-137
-55% -$14.7K 0.01% 575
2019
Q2
$32K Buy
248
+222
+854% +$30.8K 0.03% 403
2019
Q1
$3K Buy
+26
New +$3.3K ﹤0.01% 848
2018
Q3
$12K Sell
58
-29
-33% -$5.88K 0.01% 550
2018
Q2
$18K Sell
87
-473
-84% -$60.5K 0.02% 488
2018
Q1
$56K Buy
+560
New +$41.8K 0.06% 283

Other funds holding MED

Financial Gravity Asset Management's MED Position: Q3 2021 in Review

Financial Gravity Asset Management increased its Medifast (MED) stake by 40% in Q3 2021, buying an estimated $983 and bringing the position to 14 shares worth $193K. The position accounts for 0.09% of the portfolio, ranked #191.

Financial Gravity Asset Management first reported a position in MED in Q1 2018 and has held it in 10 quarters since. The position peaked at $283K in Q2 2021. 296 funds tracked by Wall St. Rank hold MED as of Q3 2021.

  • Financial Gravity Asset Management held 14 shares of Medifast worth $193K as of Q3 2021.
  • Financial Gravity Asset Management bought 4 Medifast shares in Q3 2021, an estimated $983.
  • Medifast made up 0.09% of Financial Gravity Asset Management's portfolio in Q3 2021, its #191 holding.
  • Financial Gravity Asset Management first reported a position in Medifast in Q1 2018 and has held it in 10 quarters since.
  • Financial Gravity Asset Management's Medifast position peaked at $283K in Q2 2021.
  • 296 funds tracked by Wall St. Rank held Medifast as of Q3 2021.

Based on Financial Gravity Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.